Clinical Trial Update: Over Active Bladder Instillation Study - Botox [Phase 3]

View source ↗

Summary

Phase 3 study of intravesical Botox for overactive bladder was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Detrusor Overactivity
• Overactive Bladder
• Urge Incontinence
• Urinary Incontinence

Drugs mentioned

• Botox (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Mayo Clinic | Conditions: Overactive Bladder, Urinary Urge Incontinence | Phase 3 | Status: TERMINATED | Results posted: 2014-07-11